Top Markets
Coin of the day
Mosaic ImmunoEngineering Inc. Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering Inc.

CPMV
株式のランク #38778
Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to... Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to the advancement and commercialization of an immunomodulatory platform technology. This innovative platform aims to provide therapeutic solutions for cancer and infectious diseases in both human and animal health. The company's core product is MIE-101, a nanoparticle-based treatment sourced from the cowpea mosaic virus, which has demonstrated non-infectious characteristics in mice, dogs, and humans. Headquartered in Novato, California, the company commenced operations in 2020.
株価
$0.106
最終同期: 2026-10-01
時価総額
$767.67K
変化(1日)
73.77%
変化(1年)
-84.81%
国
US
取引 Mosaic ImmunoEngineering Inc. (CPMV)

カテゴリー

Mosaic ImmunoEngineering Inc.(CPMV)のP/S比率
2026 時点のP/S比率 TTM: 0
Mosaic ImmunoEngineering Inc. の最新の財務報告および株価によると、現在のP/S比率(TTM)は 0 です。2026 年末時点でのP/S比率は 0 でした。
Mosaic ImmunoEngineering Inc. の P/S 比率の履歴(2026 ~ 2026)
各年末時点のP/S比率
年 P/S比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/S比率
企業 P/S比率 P/S比率の差 国
10.51 -
US
34.29 -
US
3.77 -
AU
11.49 -
NL
- -
CH